Cargando…
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update
PURPOSE OF REVIEW: APS ACTION is an international research network created to design and conduct large-scale, multicenter research in persistently antiphospholipid antibody (aPL)–positive patients. Given the expanding research activities of the network in the last decade since its creation, the purp...
Autores principales: | Erkan, Doruk, Sciascia, Savino, Bertolaccini, Maria Laura, Cohen, Hannah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088198/ https://www.ncbi.nlm.nih.gov/pubmed/33932165 http://dx.doi.org/10.1007/s11926-021-01008-8 |
Ejemplares similares
-
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
por: Stoots, Sarah Abramson, et al.
Publicado: (2019) -
The Role of Antiphospholipid Antibodies in COVID-19
por: Stelzer, Maximilian, et al.
Publicado: (2021) -
Epidemiology of Antiphospholipid Syndrome in the General Population
por: Dabit, Jesse Y., et al.
Publicado: (2022) -
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?
por: Foret, Thomas, et al.
Publicado: (2021) -
P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY-POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRY
por: Butt, Ayesha, et al.
Publicado: (2023)